NCT02325453 Robotic, Laparoscopic and Open Surgery for Gastric Cancer Compared on Surgical, Clinical and Oncological Outcomes Status UNKNOWN Phase N/A
NCT02322593 Phase III Study of TAS-118 Plus Oxaliplatin Versus S-1 Plus Cisplatin in Patients With Advanced Gastric Cancer Status COMPLETED Phase PHASE3
NCT02318901 Pembrolizumab and Monoclonal Antibody Therapy in Advanced Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT02318329 Open-Label, Dose-Finding Study Evaluating Safety and PK of FPA144 in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT02311595 A Phase II Clinical Trial of Reduced Port Totally Laparoscopic Distal Gastrectomy With D2 Lymph Node Dissection Status UNKNOWN Phase PHASE2
NCT02307812 Ramucirumab Use in Combination With Paclitaxel in Gastric or Gastroesophageal Junction Adenocarcinoma; Temporary Authorization for Use (ATU) in France Status APPROVED_FOR_MARKETING Phase N/A
NCT02287168 Effect of Peritoneal Lavage on Surgery-induced Positive Peritoneal Cytology in Gastric Cancer Patients Status COMPLETED Phase EARLY_PHASE1
NCT02283359 Selinexor in Combination With Irinotecan in Adenocarcinoma of Stomach and Distal Esophagus Status TERMINATED Phase PHASE1
NCT02274376 Non-Interventional Study of Xeloda (Capecitabine) in Patients With Gastric Cancer Status COMPLETED Phase N/A
NCT02272894 A Trial to Evaluate the Superior Mesenteric Vein (14V) Lymphadenectomy for Distal Advanced Gastric Cancer Status UNKNOWN Phase N/A
NCT02267343 Study of ONO-4538 in Unresectable Advanced or Recurrent Gastric Cancer Status COMPLETED Phase PHASE3
NCT02252913 A Study of Safety and Pharmacokinetics of Volitinib With Docetaxel in Patients With Advanced Gastric Cancer Status COMPLETED Phase PHASE1
NCT02250209 T- XELOX in HER2-positive Stage III Gastric Cancer After D2 Gastrectomy Status UNKNOWN Phase PHASE2
NCT02233712 Open-label, Dose-finding Study to Determine Antibody Response to G17DT Treatment in Patients With Gastric Cancer. Status COMPLETED Phase PHASE2
NCT02229058 Albumin Bound Paclitaxel Plus S-1 as the First Line Chemotherapy in Advanced or Recurrent Gastric Cancer Status COMPLETED Phase PHASE2
NCT02226380 FOLFOX6 as Neoadjuvant Chemotherapy in Local Advanced Gastric Cancer Status UNKNOWN Phase PHASE2